As per the WHO’s classification of central nervous system tumors in 2016, for the first time, diffuse gliomas were classified according to IDH1 or IDH2 mutations and the co-deletion of 1p and 19q chromosome arms10. This evidence concerns the gene IDH1 and central nervous system cancer.